Registry for patients with lymphoid cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to enhance understanding of the clinical and biological characteristics of patients diagnosed with Hodgkin lymphoma, non-Hodgkin lymphoma, and myeloma. By collecting clinical data through validated electronic charts and biological specimens, the study seeks to address issues such as treatment refractoriness and disease recurrence in a real-world setting. The data gathered will allow for analysis of treatment practices and facilitate biological studies that could have significant implications for clinical practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female patients 18 years or older
* Written informed consent
* Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma

Exclusion Criteria:

\- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma

Where it's running

• Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII
  Bergamo, Italy Recruiting

Study contacts

• Principal investigator: Alessandro Rambaldi, MD — A.O. Ospedale Papa Giovanni XXIII
• Study coordinator: Alessandro Rambaldi, MD
• Email: arambaldi@asst-pg23.it
• Phone: +39.035.2673683

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• JLM019 Injection in Adults with Advanced Cancers

  This study tests JLM019 Injection in adults with advanced solid tumors or relapsed/refractory lymphomas to see if it’s safe and tolerable.

  Recruiting Phase 1 Jecho Biopharmaceuticals Co., Ltd. · Beijing, Beijing Municipality · NCT07623850

• Cord blood transplant for children and young adults with blood cancers.

  This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.

  Recruiting Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT07566377

• Mozobil (plerixafor) to mobilize stem cells for autologous transplant

  This trial will test whether starting with G‑CSF and giving Plerixafor only when needed can collect enough stem cells for adults with multiple myeloma or lymphoma undergoing autologous transplant while possibly lowering engraftment syndrome.

  Recruiting Phase 2 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07188090

• CMV Triplex vaccine to boost immunity and prevent CMV after haploidentical stem cell transplant

  This trial tests whether giving a CMV-MVA Triplex vaccine to donors and/or recipients, with or without the antiviral letermovir, can boost CMV immunity and prevent CMV viremia in people having haploidentical stem cell transplants.

  Recruiting at 3 sites Phase 1 City of Hope Medical Center · Duarte, California and 2 other locations · NCT07020533

• Carmustine treatment for lymphoma patients

  This study is testing if adding a new drug called VI-0609 to a standard treatment helps lymphoma patients do better after a stem cell transplant.

  Recruiting at 4 sites Phase 2 Vivus LLC · Goodyear, Arizona and 3 other locations · NCT06915246

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.